Results 51 to 60 of about 8,720 (195)

Long-term cilostazol treatment reduces gliovascular damage and memory impairment in a mouse model of chronic cerebral hypoperfusion

open access: yesScientific Reports, 2017
Chronic cerebral hypoperfusion is a major cause of age-related vascular cognitive impairment. A well-characterised mouse model has shown that hypoperfusion results in gliovascular and white matter damage and impaired spatial working memory. In this study,
Akihiro Kitamura   +12 more
doaj   +1 more source

ATP Release and Purinergic Signaling Potentiate β‐Adrenergic Effects on Brown Adipocytes

open access: yesActa Physiologica, Volume 242, Issue 10, October 2026.
ABSTRACT Aim Brown adipose tissue (BAT) specializes in energy consumption and thermogenesis in response to cold stress. Brown adipocytes (BA) express purinergic receptors, yet little is known about the source of extracellular ATP and the role of purinergic signaling, and the potential interaction with β‐adrenergic signaling.
Marco Tozzi   +8 more
wiley   +1 more source

Premature Ventricular Contractions (PVCs) Induced by Administration of Cilostazol after Myocardial Infarction

open access: yesRussian Open Medical Journal, 2013
Cilostazol is a phosphodiesterase III inhibitor, which was approved by FDA (food and drug administration) for intermittent claudication in 1999. What made it known to cardiologists is the Cilostazol for Restenosis Trial (CREST), in which cilostazol was ...
Lihua Zhong   +3 more
doaj  

Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database

open access: yesBMC Cardiovascular Disorders, 2018
Background Cilostazol has been associated with spontaneous reports of cardiovascular adverse events and serious bleeding. The objective of this study is to determine the relative risk of cardiovascular adverse events or haemorrhages in patients with ...
Jordi Real   +9 more
doaj   +1 more source

Structure‐Guided Optimization of PDE9A Inhibitors Tackling Neuroinflammation: A Combined Computational and In Vitro Study

open access: yesChemMedChem, Volume 21, Issue 17, 14 September 2026.
Computational studies allowed the identification of a PDE9A inhibitor. A novel HPLC‐based assay was developed and optimized to measure enzyme function to assess PDE9A inhibition. Furthermore, in vitro tests supported the activity of the compound against neuroinflammation. Oxidative stress and inflammation are key players in central nervous system (CNS)
Giovanni Ribaudo   +10 more
wiley   +1 more source

EFFECTS OF ROSUVASTATIN IN EXPERIMENTALLY-INDUCED CARDIAC ISCHEMIA AND ON AORTIC VASCULAR REACTIVITY. [PDF]

open access: yesAl-Azhar Journal of Pharmaceutical Sciences, 2017
Myocardial infarction (MI) continues to be a major public health problem in the world. The present study aimed to elucidate the protective effect of  different doses  of rosuvastatin and cilostazol, as well as their combination on isoprenaline-induced MI
Maryam Hamouda
doaj   +1 more source

Validation of the European Society of Cardiology Ischemic and Bleeding Risk Criteria for Risk Stratification After Endovascular Therapy in Japanese Patients With Lower Extremity Artery Disease

open access: yesCatheterization and Cardiovascular Interventions, Volume 108, Issue 3, Page 801-815, September 1, 2026.
ABSTRACT Background The European Society of Cardiology (ESC) guidelines for peripheral artery disease recommend antithrombotic strategies based on high ischemic risk (HIR) and high bleeding risk (HBR) criteria. However, their prognostic value in patients with lower extremity artery disease (LEAD) undergoing endovascular therapy (EVT) remains unclear ...
Hirokazu Shimono   +8 more
wiley   +1 more source

A cilostazol polimorfiája

open access: yes, 2020
A dolgozatban a cilostazol polimorfiáját vizsgáltam és a polimorf módosulatok pordiffrakciós vizsgálatával foglalkoztam. A hatóanyag polimorf módosulatainak meghatározása mellett kokristály képzést kíséreltem meg.
Szőke, László
core  

Effects of cilostazol administration on the fertility of female mice.

open access: yes, 2012
(A) treated with cilostazol, (B) treatment with cilostazol stopped. The value of the litter size is not a percentage, but numerical data. In image (A), Black solid rectangle represents cilostazol treatment group, and black hollow rectangle represents ...
Yue Zhao (186573)   +8 more
core   +1 more source

Spectrophotometric Determination of Cilostazol in Tablet Dosage Form [PDF]

open access: yes, 2010
Purpose: To develop simple, rapid and selective spectrophotometric methods for the determination of cilostazol in tablet dosage form. Methods: Cilostazol was dissolved in 50 % methanol and its absorbance was scanned by ultraviolet (UV) spectrophotometry.
Kumar, V   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy